Diaceutics PLC (FRA:7DC)

Market Cap	142.31M +6.0%
Revenue (ttm)	44.06M +19.5%
Net Income	111.19K
EPS	0.00
Shares Out	n/a
PE Ratio	1,279.86
Forward PE	174.01
Dividend	n/a
Ex-Dividend Date	n/a

Volume	525
Open	1.610
Previous Close	1.610
Day's Range	1.610 - 1.650
52-Week Range	1.390 - 2.020
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 23, 2026

About Diaceutics

Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies. The company offers DXRX, a diagnostic commercialization platform for precision medicine that integrates multiple pipelines of diagnostic testing data from a network of laboratories. It also provides DXRX data solutions, including DXRX Signal, that enables potential therapy eligibility for patients within hours of a diagnostic event, enabling teams to act while treatment decisions are still pending;...

• Industry: Commercial Physical and Biological Research
• Founded: 2005
• Employees: 205
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 7DC

Financial Performance

Financial numbers in GBP

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Aug 27, 2026

Data Sources Report a data error